| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.
|
Ann Intern Med
|
2004
|
17.79
|
|
2
|
Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria.
|
Circulation
|
2004
|
3.35
|
|
3
|
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
|
J Am Coll Cardiol
|
2008
|
2.99
|
|
4
|
Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
|
Circ Cardiovasc Imaging
|
2012
|
2.62
|
|
5
|
Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2006
|
2.40
|
|
6
|
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis.
|
Am J Epidemiol
|
2011
|
2.38
|
|
7
|
Electrocardiographic features of arrhythmogenic right ventricular dysplasia.
|
Circulation
|
2009
|
2.22
|
|
8
|
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
|
Eur Heart J
|
2006
|
2.21
|
|
9
|
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Circ Cardiovasc Genet
|
2009
|
2.19
|
|
10
|
Long-term single procedure efficacy of catheter ablation of atrial fibrillation.
|
J Interv Card Electrophysiol
|
2006
|
2.05
|
|
11
|
Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
|
J Am Coll Cardiol
|
2010
|
1.97
|
|
12
|
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Am J Hum Genet
|
2006
|
1.85
|
|
13
|
Beat-to-beat three-dimensional ECG variability predicts ventricular arrhythmia in ICD recipients.
|
Heart Rhythm
|
2010
|
1.85
|
|
14
|
Does left atrial volume and pulmonary venous anatomy predict the outcome of catheter ablation of atrial fibrillation?
|
J Cardiovasc Electrophysiol
|
2009
|
1.84
|
|
15
|
Complications of catheter ablation for atrial fibrillation: incidence and predictors.
|
J Cardiovasc Electrophysiol
|
2008
|
1.81
|
|
16
|
Automated detection and characterization of complex fractionated atrial electrograms in human left atrium during atrial fibrillation.
|
Heart Rhythm
|
2007
|
1.80
|
|
17
|
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations.
|
Circulation
|
2006
|
1.79
|
|
18
|
Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2008
|
1.75
|
|
19
|
Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2009
|
1.74
|
|
20
|
QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.
|
Arch Intern Med
|
2011
|
1.73
|
|
21
|
Electrocardiographic QT interval and mortality: a meta-analysis.
|
Epidemiology
|
2011
|
1.62
|
|
22
|
Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle.
|
J Am Coll Cardiol
|
2006
|
1.55
|
|
23
|
Radiation exposure during catheter ablation of atrial fibrillation.
|
Circulation
|
2004
|
1.44
|
|
24
|
Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Am Heart J
|
2010
|
1.44
|
|
25
|
Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2007
|
1.44
|
|
26
|
Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease.
|
J Cardiovasc Electrophysiol
|
2009
|
1.43
|
|
27
|
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
|
Circulation
|
2010
|
1.31
|
|
28
|
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
|
J Am Heart Assoc
|
2013
|
1.30
|
|
29
|
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
|
J Am Coll Cardiol
|
2011
|
1.29
|
|
30
|
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
|
Oncologist
|
2012
|
1.18
|
|
31
|
Transoesophageal echocardiography predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.
|
Europace
|
2010
|
1.18
|
|
32
|
Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation.
|
J Cardiovasc Electrophysiol
|
2006
|
1.13
|
|
33
|
Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2.
|
Hum Mutat
|
2006
|
1.13
|
|
34
|
Progressive dilation of the ascending aorta in children with isolated bicuspid aortic valve.
|
Am J Cardiol
|
2007
|
1.08
|
|
35
|
A new electrocardiogram marker to identify patients at low risk for ventricular tachyarrhythmias: sum magnitude of the absolute QRST integral.
|
J Electrocardiol
|
2010
|
1.07
|
|
36
|
Predictors of high defibrillation threshold in the modern era.
|
Pacing Clin Electrophysiol
|
2012
|
1.05
|
|
37
|
A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2009
|
1.05
|
|
38
|
Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Circ Arrhythm Electrophysiol
|
2012
|
1.01
|
|
39
|
Association of body mass index, metabolic syndrome, and leukocyte count.
|
Am J Cardiol
|
2006
|
1.01
|
|
40
|
Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
|
Heart Rhythm
|
2005
|
1.01
|
|
41
|
Correlation of left atrial diameter by echocardiography and left atrial volume by computed tomography.
|
J Cardiovasc Electrophysiol
|
2009
|
1.01
|
|
42
|
Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Am J Cardiol
|
2006
|
1.00
|
|
43
|
Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging.
|
J Cardiovasc Electrophysiol
|
2005
|
1.00
|
|
44
|
Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation.
|
J Cardiovasc Electrophysiol
|
2006
|
0.99
|
|
45
|
Atrial volume reduction following catheter ablation of atrial fibrillation and relation to reduction in pulmonary vein size: an evaluation using magnetic resonance angiography.
|
J Interv Card Electrophysiol
|
2005
|
0.99
|
|
46
|
Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Heart Rhythm
|
2009
|
0.98
|
|
47
|
Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance.
|
J Am Soc Echocardiogr
|
2007
|
0.97
|
|
48
|
Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation.
|
Europace
|
2009
|
0.94
|
|
49
|
Coffee, alcohol, smoking, physical activity and QT interval duration: results from the Third National Health and Nutrition Examination Survey.
|
PLoS One
|
2011
|
0.92
|
|
50
|
Prospective comparison of the diagnostic utility of a standard event monitor versus a "leadless" portable ECG monitor in the evaluation of patients with palpitations.
|
J Interv Card Electrophysiol
|
2008
|
0.91
|
|
51
|
Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakophilin-2 mutation.
|
J Cardiovasc Electrophysiol
|
2008
|
0.91
|
|
52
|
Demographic profile of patients undergoing catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2011
|
0.91
|
|
53
|
Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
J Cardiovasc Transl Res
|
2010
|
0.90
|
|
54
|
Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation.
|
J Interv Card Electrophysiol
|
2009
|
0.89
|
|
55
|
Long- and short-term temporal stability of complex fractionated atrial electrograms in human left atrium during atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2008
|
0.89
|
|
56
|
Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Am J Cardiol
|
2007
|
0.89
|
|
57
|
Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men.
|
Am J Cardiol
|
2005
|
0.88
|
|
58
|
Safety and efficacy of circumferential pulmonary vein catheter ablation of atrial fibrillation.
|
Heart Rhythm
|
2005
|
0.88
|
|
59
|
Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2009
|
0.87
|
|
60
|
Circumferential ablation with pulmonary vein isolation in permanent atrial fibrillation.
|
Am J Cardiol
|
2007
|
0.86
|
|
61
|
Impact of heart rhythm status on registration accuracy of the left atrium for catheter ablation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2007
|
0.86
|
|
62
|
Reader- and instrument-dependent variability in the electrocardiographic assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
J Cardiovasc Electrophysiol
|
2010
|
0.85
|
|
63
|
Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Am J Cardiol
|
2007
|
0.84
|
|
64
|
Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
J Am Coll Cardiol
|
2012
|
0.84
|
|
65
|
Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
J Am Coll Cardiol
|
2009
|
0.84
|
|
66
|
Failure in short-term prediction of ventricular tachycardia and ventricular fibrillation from continuous electrocardiogram in intensive care unit patients.
|
J Electrocardiol
|
2010
|
0.83
|
|
67
|
Serum 25-hydroxyvitamin D, calcium, phosphorus, and electrocardiographic QT interval duration: findings from NHANES III and ARIC.
|
J Clin Endocrinol Metab
|
2011
|
0.81
|
|
68
|
Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Am J Cardiol
|
2005
|
0.81
|
|
69
|
Conventional pulmonary vein isolation compared with the "box isolation" method: a randomized clinical trial.
|
J Interv Card Electrophysiol
|
2011
|
0.80
|
|
70
|
Regional differences in systolic and diastolic function in arrhythmogenic right ventricular dysplasia/cardiomyopathy using magnetic resonance imaging.
|
Am J Cardiol
|
2005
|
0.80
|
|
71
|
Incidence of atherosclerotic cardiovascular disease among HIV patients receiving dialysis.
|
Am J Kidney Dis
|
2006
|
0.75
|
|
72
|
Efficacy of multidisciplinary outpatient management (MOM) program in long term heart failure care.
|
South Med J
|
2010
|
0.75
|